Cargando…

The fate of medications evaluated for ischemic stroke pharmacotherapy over the period 1995–2015

Stroke is a brain damage caused by a loss of blood supply to a portion of the brain, which requires prompt and effective treatment. The current pharmacotherapy for ischemic stroke primarily relies on thrombolysis using recombinant tissue plasminogen activators (rt-PAs) to breakdown blood clots. Neur...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiaoling, Wang, Kewei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071630/
https://www.ncbi.nlm.nih.gov/pubmed/27818918
http://dx.doi.org/10.1016/j.apsb.2016.06.013

Ejemplares similares